Key players operating in the protein assays market include Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), Abcam plc (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
Protein Assays Market by type 2017-2022 by new Service spreads across 126 pages profiling 13 companies and supported with 61 tables and 33 figures available at ReportsandReports.com
Get Sample Copy for Professional Insights @ www.reportsnreports.com/contacts/r…spx?name=1011554
The protein assays market is expected to reach USD 1.42 billion by 2017 and is projected to grow at a CAGR of 11.1% between 2017 and 2022, to reach USD 2.41 billion in 2022. Protein assays are used in life science research to determine the total protein concentration.
Estimation of protein concentration is necessary for protein purification, electrophoresis, cell biology, molecular biology, and research applications. The protein assays market is witnessing high growth due to factors such as increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research.
The global protein assays market is segmented based on type, product, technology, application, end user, and region. The protein assays market by product is segmented into reagents, kits, and instruments & accessories.
The reagents segment is expected to witness the highest growth during the forecast period, primarily due to the repeated purchases of reagents, unlike instruments that are considered a one-time investment. The market by type is segmented into dye-binding assays, copper-ion-based assays; test strip-based assays, and other protein assays.
The dye-binding assays segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing usage of dye-binding assays in disease diagnosis.
On the basis application, the market is segmented into disease diagnosis, drug discovery and development, and other applications (protein purification; electrophoresis; cell biology; molecular biology; host cell protein assays; and protein identification with blood groups, cell surface markers, drugs, and toxins). The disease diagnosis segment is projected to be the fastest-growing market during the forecast year.
This can be attributed to the increasing adoption of protein assays used to diagnose cancer; immune system diseases; and liver, kidney, and bone marrow diseases.
Complete Browse Here@ www.reportsnreports.com/reports/10…-ts-to-2022.html
Protein Assays Market, By Type
Test Strip-Based Assays
Other Protein Assays
Protein Assays Market, By Product
Instruments and Accessories
Protein Assays Market, By Technology
Absorbance-Based Protein Assays
Colorimetric Protein Assays
Fluorescence-Based Protein Assays
Key Players from Table of Content
13 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Bio-Rad Laboratories, Inc.
13.2 Thermo Fisher Scientific Inc.
13.3 Merck KGaA
13.4 Promega Corporation
13.5 GE Healthcare
13.6 Perkinelmer, Inc.
13.7 Geno Technology, Inc.
13.8 Cell Signaling Technology, Inc.
13.9 Abcam PLC.
13.10 Novus Biologicals, LLC
13.11 Soltec Ventures (Soltec Bio Science)
13.12 Lonza Group
13.13 Biovision Inc.
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.